BTOG - British Thoracic Oncology Group

BTOG Does ... HER2

Dr Tom Newsom-Davis, Consultant in Medical Oncology at Chelsea and Westminster Hospital and Dr Emma O’Dowd, Consultant Respiratory Physician/Honorary Associate Professor at Nottingham University Hospitals NHS Trust/University of Nottingham were joined by Dr Riyaz Shah, Consultant Medical Oncologist at the Kent Oncology Centre to talk about the HER2 Mutation. 

BTOG does … MET

BTOG does … MET Podcast is now released – this is part 5 of a series looking at mutations in lung cancer – we have already looked at BRAF, KRAS, RET and ROS1.

Recorded recently, Dr Tom Newsom-Davis, BTOG Steering Committee Chair-Elect discussed MET with Dr Alastair Greystoke, Senior Lecturer and Honorary Consultant in Medical Oncology at University of Newcastle upon Tyne.

BTOG Webinar: WCLC/ESMO 2024 Update

Led by Tom Newsom-Davis, this webinar covered clinically impactful thoracic oncology highlights of both WCLC 2024 and ESMO 2024.

WCLC 2024 Highlights - Martin Forster, Consultant Medical Oncologist and Associate Professor, University College Hospital

ESMO 2024 Metastatic Disease Highlights - Meenali Chitnis, Consultant Medical Oncologist, Oxford Cancer & Haematology Centre

ESMO 2024 Early and Locally Advanced Disease Highlights - Yvonne Summers, Consultant in Medical Oncology, The Christie NHS Foundation Trust

Panel Discussion led by Chair

BTOG Webinar: ASCO 2024 Update

Led by Tom Newsom-Davis, this webinar covered clinically impactful thoracic oncology highlights of ASCO 2024 held May 31 - June 4 in Chicago.

Broadcast live on Monday 17 June 2024 18.00-19.15

Targeted Therapies in Advanced Stage NSCLC Dr Louise Lim, Consultant Medical Oncologist, St Bartholomew's Hospital

Immunotherapy in Advanced Stage NSCLC Dr Tom Newsom-Davis, Consultant in Medical Oncology, Chelsea and Westminster Hospital

Locally Advanced NSCLC, Small Cell Carcinoma and Mesothelioma Dr Riyaz Shah, Consultant Medical Oncologist, Kent Oncology Centre, Maidstone and Tunbridge Wells NHS Trust

Panel Discussion led by Chair

BTOG does … Stage III Non-Small Cell Lung Cancer (NSCLC)

Dr Tom Newsom-Davis, BTOG Steering Committee Vice-Chair and Chair Elect is joined for this podcast by clinical oncology colleagues, Professor Corinne Faivre-Finn, Professor of Thoracic Radiation Oncology, University of Manchester and Honorary Consultant Clinical Oncologist, The Christie NHS Foundation Trust and Dr Fiona McDonald, Consultant Clinical Oncologist, The Royal Marsden NHS Foundation Trust. 

BTOG-NLCA Webinar: The State of the Nation

Chaired by Neal Navani, NLCA Senior Clinical Lead and BTOG Steering Committee Member, this webinar presented the NLCA State of the Nation Report 2024.

BTOG Does … Mesothelioma and Surgery

Following on from Professor Eric Lim’s presentation “MARS2: results and UK implications” at BTOG 2024, Dr Tom Newsom-Davis, BTOG Steering Committee Chair-Elect, discusses Mesothelioma and Surgery with Professor Eric Lim, Consultant Thoracic Surgeon, Royal Brompton Hospital and Professor of Thoracic Surgery, Imperial College London and Mr David Waller, Consultant Thoracic Surgeon at Barts Health NHS Trust. 

BTOG does … the BTS Pleural Guidelines

Dr Tom Newsom-Davis, BTOG Steering Committee Vice-Chair talks to Professor Najib M Rahman, Professor of Respiratory Medicine, Director, Oxford Respiratory Trials Unit and Nuffield Department of Medicine, University of Oxford

BTOG Does ... ROS1

Dr Tom Newsom-Davis, BTOG Steering Committee Vice-Chair talks to Dr Meenali Chitnis, Consultant Medical Oncologist at Oxford University Hospitals NHS Foundation Trust.

BTOG does ... RET

BTOG does ... RET  – this is part 3 of a series looking at mutations in lung cancer – we have already looked at BRAF and KRAS.  Dr Tom Newsom-Davis, BTOG Steering Committee Vice-Chair talks to Dr Nadza Tokaca, Consultant Medical Oncologist at the Royal Marsden Hospital.